17-59954062-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_016125.4(RNFT1):āc.1156A>Gā(p.Ile386Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000183 in 1,586,600 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_016125.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNFT1 | NM_016125.4 | c.1156A>G | p.Ile386Val | missense_variant | 8/9 | ENST00000305783.13 | NP_057209.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNFT1 | ENST00000305783.13 | c.1156A>G | p.Ile386Val | missense_variant | 8/9 | 1 | NM_016125.4 | ENSP00000304670 | P1 | |
RNFT1 | ENST00000482446.5 | c.*317A>G | 3_prime_UTR_variant, NMD_transcript_variant | 7/8 | 1 | ENSP00000436144 | ||||
RNFT1 | ENST00000486103.6 | n.657A>G | non_coding_transcript_exon_variant | 4/4 | 5 | |||||
RNFT1 | ENST00000466544.5 | c.*459A>G | 3_prime_UTR_variant, NMD_transcript_variant | 6/7 | 2 | ENSP00000436533 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000130 AC: 3AN: 230272Hom.: 0 AF XY: 0.00000796 AC XY: 1AN XY: 125698
GnomAD4 exome AF: 0.0000160 AC: 23AN: 1434394Hom.: 0 Cov.: 28 AF XY: 0.0000126 AC XY: 9AN XY: 714126
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74368
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at